furosemide has been researched along with cyclic gmp in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (31.25) | 18.7374 |
| 1990's | 12 (37.50) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Clasen, U; Hawlina, A; Heidenreich, O; Osswald, H | 1 |
| Bankuzova, EV; Nekrasova, AA; Shkhvatsabaia, IK; Speranskaia, NV | 1 |
| Angermann, CE; Dominiak, P; Gerzer, R; Kemkes, BM; Spes, CH; Stempfle, HU; Theisen, K; Weil, J | 1 |
| Donker, AJ; Hackeng, WH; Meuwissen, SG; van Vliet, AA | 1 |
| Hayashi, K; Kido, H; Uchida, T; Watanabe, M; Yamanaga, K | 1 |
| Charles, CJ; Espiner, EA; Fitzpatrick, MA; Ikram, H; Rademaker, MT; Sybertz, E; Yandle, TG | 1 |
| Jespersen, B; Pedersen, EB; Sørensen, SS | 1 |
| Jensen, L; Jespersen, B; Pedersen, EB; Sørensen, SS | 1 |
| Danielsen, H; Jespersen, B; Pedersen, EB | 1 |
| Gerzer, R; Theisen, K; Wehling, M; Weil, J; Zimmermann, J | 1 |
| Kim, HD; Sergeant, S; Sohn, DH | 1 |
| Broqvist, M; Dahlström, U; Karlberg, BE; Karlsson, E; Marklund, T | 1 |
| Cragoe, EJ; Oyarzabal, H; Sellin, JH | 1 |
| Blaine, EH; Marsh, EA; Napier, MA; Seymour, AA | 1 |
| Ernst, SA; Lowy, RJ | 1 |
| Green, K; Mayberry, L | 1 |
| Matsui, N; Ogawa, K | 1 |
| Lelekova, TV; Serbeniuk, TsV | 1 |
| Angeli, P; Arroyo, V; Brenner, BM; Guo, J; Jiménez, W; Mackenzie, HS; Ros, J; Troy, JL; Zhang, PL | 1 |
| Fink, E; Hropot, M; Linz, W; Schölkens, BE; Wiemer, G; Wohlfart, P | 1 |
| Ikeda, K; Takasaka, T; Wu, D | 1 |
| Charles, CJ; Espiner, EA; Fitzpatrick, MA; Nicholls, MG; Rademaker, MT; Richards, AM; Sybertz, E | 1 |
| Doba, N; Tomiyama, H; Watanabe, G; Yamashina, A; Yoshida, H | 1 |
| Orda, A; Przewłocka-Kosmala, M; Salomon, P | 1 |
| Boerrigter, G; Burnett, JC; Cataliotti, A; Chen, HH; Costello-Boerrigter, LC; Heublein, DM; Malatino, LS; Schirger, JA; Tsuruda, T | 1 |
| Bukanova, JV; Skrebitsky, VG; Solntseva, EI | 1 |
| Beierwaltes, WH | 1 |
| Burnett, JC; Cataliotti, A; Chen, HH; Martin, FL | 1 |
| Babelova, A; Burckhardt, BC; Burckhardt, G; Henjakovic, M; Wegner, W | 1 |
| Castrop, H; Hofmann, F; Limmer, F; Schinner, E; Schlossmann, J; Vitzthum, H | 1 |
| Burnett, JC; Chen, HH; Dzhoyashvili, NA; Iyer, SR | 1 |
3 review(s) available for furosemide and cyclic gmp
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
Effects of atrial natriuretic factor on renal function and cyclic GMP production.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium; Cyclic GMP; Enzyme Activation; Furosemide; Glomerular Filtration Rate; Guanylate Cyclase; Hydrochlorothiazide; Hypertension; Kidney; Kidney Tubules; Muscle, Smooth, Vascular; Natriuresis; Rats; Rats, Inbred SHR; Vasodilation | 1986 |
Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
Topics: Acute Disease; Cyclic GMP; Diuretics; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Renin-Angiotensin System; Risk Factors; Sodium Potassium Chloride Symporter Inhibitors; Vasodilator Agents | 2008 |
2 trial(s) available for furosemide and cyclic gmp
| Article | Year |
|---|---|
[Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
Topics: Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Coronary Disease; Cyclic GMP; Deoxyepinephrine; Diuretics; Dopamine; Electrolytes; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Natriuresis; Urodynamics | 1990 |
Reduction of oxidative stress augments natriuretic effect of furosemide in moderate heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Cross-Over Studies; Cyclic GMP; Drug Therapy, Combination; Enalapril; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Oxidative Stress | 2003 |
27 other study(ies) available for furosemide and cyclic gmp
| Article | Year |
|---|---|
Tissue levels of cyclic nucleotides in the rat kidney after administration of furosemide.
Topics: Animals; Cyclic AMP; Cyclic GMP; Furosemide; Kidney; Male; Rats | 1977 |
[Cyclic nucleotides in the blood plasma in arterial hypertension].
Topics: Cyclic AMP; Cyclic GMP; Epinephrine; Furosemide; Humans; Hypertension; Nucleotides, Cyclic; Physical Exertion; Time Factors | 1978 |
Effects of graded exercise on blood pressure, heart rate, and plasma hormones in cardiac transplant recipients before and during antihypertensive therapy.
Topics: Adult; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Drug Therapy, Combination; Enalapril; Epinephrine; Exercise Test; Female; Follow-Up Studies; Furosemide; Heart Rate; Heart Transplantation; Hormones; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Postoperative Complications; Renin; Verapamil | 1992 |
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Captopril; Creatinine; Cyclic GMP; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Kidney; Liver; Liver Cirrhosis; Male; Middle Aged; Renal Dialysis; Renin; Sodium; Spironolactone | 1992 |
Torasemide, but not frusemide, increases intracellular cAMP and cGMP content in the aorta of the renal hypertensive rat.
Topics: Animals; Aorta; Blood Pressure; Cyclic AMP; Cyclic GMP; Diuretics; Furosemide; Hypertension, Renovascular; Male; Rats; Rats, Inbred Strains; Sulfonamides; Torsemide | 1992 |
Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
Topics: Analysis of Variance; Animals; Atrial Natriuretic Factor; Blood Pressure; Cattle; Cyclic GMP; Dipeptides; Diuresis; Female; Furosemide; Heart Failure; Hemodynamics; Injections, Intravenous; Natriuresis; Neprilysin | 1992 |
Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
Topics: Adult; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Volume; Body Water; Cyclic GMP; Dinoprostone; Female; Furosemide; Humans; Male; Middle Aged; Nephrotic Syndrome; Sodium | 1991 |
Atrial natriuretic factor, cyclic 3',5'-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide.
Topics: Adult; Aged; Ascites; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Dinoprostone; Diuresis; Female; Furosemide; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuresis | 1990 |
Atrial natriuretic peptide and blood volume in patients with chronic glomerulonephritis: effects of albumin and frusemide administration.
Topics: Adult; Albumins; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Volume; Cyclic GMP; Diuresis; Female; Furosemide; Glomerulonephritis; Humans; Male; Middle Aged; Natriuresis | 1990 |
Volume-activated Na/H exchange activity in fetal and adult pig red cells: inhibition by cyclic AMP.
Topics: Amiloride; Animals; Carrier Proteins; Cell Membrane Permeability; Chlorides; Cyclic AMP; Cyclic GMP; Erythrocytes; Furosemide; Hydrogen; Osmosis; Potassium; Sodium; Sodium-Hydrogen Exchangers; Swine; Time Factors | 1989 |
Neuroendocrine response in acute heart failure and the influence of treatment.
Topics: Acute Disease; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Catecholamines; Cyclic GMP; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Neurotransmitter Agents | 1989 |
Electrogenic sodium absorption in rabbit cecum in vitro.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amiloride; Animals; Bicarbonates; Biological Transport; Cecum; Chlorides; Cyclic GMP; Dose-Response Relationship, Drug; Electric Conductivity; Electrophysiology; Epinephrine; Furosemide; Intestinal Absorption; Male; Potassium; Rabbits; Sodium; Sulfhydryl Reagents; Water-Electrolyte Balance | 1988 |
Beta-adrenergic stimulation of ion transport in primary cultures of avian salt glands.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-Agonists; Animals; Atropine; Biological Transport, Active; Carbachol; Cells, Cultured; Colforsin; Cyclic GMP; Ducks; Epinephrine; Furosemide; Ions; Kinetics; Ouabain; Phentolamine; Propranolol; Salt Gland | 1987 |
Drug effects on the hydraulic conductivity of the isolated rabbit ciliary epithelium.
Topics: Amiloride; Animals; Body Fluids; Ciliary Body; Cyclic GMP; Epithelium; Ethacrynic Acid; Ferricyanides; Furosemide; In Vitro Techniques; Rabbits; Sympathomimetics; Theophylline | 1985 |
The effects of furosemide on adenosine 3':5'-cyclic monophosphate, guanosine 3':5'-cyclic monophosphate and corticosterone production stimulated by adrenocorticotropin in monolayer cultured rat adrenal cells.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Bucladesine; Calcium; Cells, Cultured; Corticosterone; Cyclic AMP; Cyclic GMP; Furosemide; Intracellular Fluid; Male; Protein Binding; Rats; Rats, Inbred Strains | 1986 |
[Participation of cGMP in inhibitory mechanisms of the center of amphibian lymph hearts].
Topics: Animals; Bucladesine; Cyclic GMP; Depression, Chemical; Furosemide; gamma-Aminobutyric Acid; In Vitro Techniques; Lymphatic System; Neural Inhibition; Rana temporaria | 1987 |
HS-142-1, a potent antagonist of natriuretic peptides in vitro and in vivo.
Topics: Animals; Arginine; Atrial Natriuretic Factor; Cell Line; Cyclic GMP; Furosemide; Glomerular Filtration Rate; Male; Natriuresis; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nerve Tissue Proteins; Peptide Fragments; Polysaccharides; Proteins; Rats; Rats, Wistar; Receptors, Atrial Natriuretic Factor | 1994 |
Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin.
Topics: Animals; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Epoprostenol; Furosemide; Kinins; Nitric Oxide | 1994 |
Cellular mechanisms in activation of Na-K-Cl cotransport in nasal gland acinar cells of guinea pigs.
Topics: Acetylcholine; Alkaloids; Animals; Benzophenanthridines; Biological Transport; Bucladesine; Bumetanide; Calcium; Calmodulin; Carrier Proteins; Charybdotoxin; Cholinergic Fibers; Cyclic AMP; Cyclic GMP; Enzyme Inhibitors; Exocrine Glands; Furosemide; Guinea Pigs; Ionomycin; Ionophores; Isoquinolines; Nasal Cavity; Phenanthridines; Protein Kinase Inhibitors; Protein Kinases; Second Messenger Systems; Signal Transduction; Sodium; Sodium-Potassium-Chloride Symporters; Sulfonamides; Tetradecanoylphorbol Acetate; Trifluoperazine; Vasoactive Intestinal Peptide | 1995 |
Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
Topics: Animals; Atrial Natriuretic Factor; Captopril; Cyclic GMP; Dipeptides; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Heart Failure; Hemodynamics; Neprilysin; Sheep | 1996 |
[Plasma levels of brain natriuretic peptide, cyclic 3'5'-guanosine monophosphate, endothelin 1, and noradrenaline in patients with chronic congestive heart failure].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cyclic GMP; Diuretics; Dose-Response Relationship, Drug; Endothelin-1; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Radioimmunoassay; Time Factors | 2003 |
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Topics: Animals; Cardiac Output; Cardiac Pacing, Artificial; Cyclic GMP; Diuresis; Diuretics; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Furosemide; Glomerular Filtration Rate; Heart Failure; Mineralocorticoid Receptor Antagonists; Natriuresis; Natriuretic Peptide, Brain; Norepinephrine; Renal Circulation; Renin-Angiotensin System | 2004 |
Cyclic nucleotides induce long-term augmentation of glutamate-activated chloride current in molluscan neurons.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Cell Membrane; Chloride Channels; Cyclic GMP; Furosemide; GABA Antagonists; Ganglia, Invertebrate; Glutamic Acid; Helix, Snails; In Vitro Techniques; Learning; Long-Term Potentiation; Membrane Potentials; Memory; Neurons; Nucleotides, Cyclic; Patch-Clamp Techniques; Picrotoxin; Sodium Potassium Chloride Symporter Inhibitors; Synaptic Transmission | 2005 |
cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic AMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 5; Furosemide; Kinetics; Male; Milrinone; Nitric Oxide; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Rats; Rats, Sprague-Dawley; Renin; Second Messenger Systems | 2006 |
Sex-differences in renal expression of selected transporters and transcription factors in lean and obese Zucker spontaneously hypertensive fatty rats.
Topics: Animals; Biological Transport; Blood Pressure; Cyclic GMP; Diabetes Mellitus; Diabetic Nephropathies; Female; Furosemide; Gene Expression Profiling; Gene Expression Regulation; HEK293 Cells; Humans; Kidney; Male; Obesity; Organic Anion Transporters, Sodium-Independent; Rats; Rats, Inbred SHR; Rats, Zucker; RNA, Messenger; Sex Factors; Transcription Factors | 2015 |
Regulation of the Na(+)-K(+)-2Cl(-) cotransporter by cGMP/cGMP-dependent protein kinase I after furosemide administration.
Topics: Animals; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Female; Furosemide; Kidney; Male; Mice, Knockout; Mice, Transgenic; Microfilament Proteins; Phosphoproteins; Phosphorylation; Potassium; Renin; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 1 | 2015 |
MANP (M-Atrial Natriuretic Peptide) Reduces Blood Pressure and Furosemide-Induced Increase in Aldosterone in Hypertension.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Furosemide; Guanosine Monophosphate; Hypertension; Natriuresis; Rats | 2022 |